NCT05382221

Brief Summary

This study will evaluate Comprehensive Chronic Care (CCC), a healthcare treatment approach designed to increase smoking treatment engagement and abstinence among primary care patients who smoke. This research will compare CCC with Standard of Care (SC) on the following outcomes: abstinence at 18 months (primary outcome), treatment reach, and cost-effectiveness. Participation in the study will last 18 months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
979

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

August 8, 2022

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 25, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 25, 2025

Completed
Last Updated

December 18, 2025

Status Verified

December 1, 2025

Enrollment Period

3.1 years

First QC Date

May 16, 2022

Last Update Submit

December 17, 2025

Conditions

Keywords

Chronic Care Tobacco TreatmentStandard of CareReduction TreatmentMotivation Phase Treatment

Outcome Measures

Primary Outcomes (1)

  • Number of Participants with biochemically confirmed point-prevalence abstinence at 18 months

    Group differences in abstinence at 18 months will be evaluated using logistic regression.

    up to 18 months

Secondary Outcomes (5)

  • Number of Participants with 7-day point-prevalence abstinence at 6 months

    6 months

  • Number of Participants with 7-day point-prevalence abstinence at 12 months

    12 months

  • Group differences in Cessation Treatment

    Up to 18 months

  • Total Cost of Intervention

    Up to 18 months

  • Cost Effectiveness measured by incremental cost-effectiveness ratio (ICER)

    Up to 18 months

Study Arms (2)

Comprehensive Chronic Care

EXPERIMENTAL

ongoing proactive outreach designed to provide support and information about evidence-based smoking treatment, with access to individually validated treatments that are appropriate for patients who are: 1) unwilling quit but willing to reduce; 2) ready to quit; and 3) recovering from an unsuccessful quit attempt

Other: Comprehensive Chronic Care

Standard Care

ACTIVE COMPARATOR

involves one offer of cessation treatment (8 weeks of nicotine patch plus referral to the tobacco quit line), annually

Other: Standard Care

Interventions

Those randomized to CCC will receive smoking treatment offers via the following routes: 1) Four Outreach Calls from a Health Counselor at 4, 8, 12, and 14 months post-study enrollment; 2) Four texts and/or mailings (depending on healthcare system preferences) over 14 months. These outreach contacts will offer cessation treatment or reduction treatment.

Comprehensive Chronic Care

one offer of cessation treatment annually

Standard Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • On smoking registry at a participating clinic OR report current smoking at a clinic visit
  • Smoked cigarettes every day in the past 30 days (with or without other forms of tobacco or nicotine)
  • Able to participate in informed consent activities (e.g., reports understanding the nature of the study and consent)
  • Able to speak and read English.

You may not qualify if:

  • Activated healthcare power of attorney or cognitive impairment that would preclude informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

UW Health

Madison, Wisconsin, 53792, United States

Location

Advocate Aurora

Milwaukee, Wisconsin, 53204, United States

Location

MeSH Terms

Conditions

Smoking Cessation

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Jessica Cook, PhD

    UW Center of Tobacco Research and Intervention

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 16, 2022

First Posted

May 19, 2022

Study Start

August 8, 2022

Primary Completion

September 25, 2025

Study Completion

September 25, 2025

Last Updated

December 18, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations